Xylosyltransferase I variants and their impact on abdominal aortic aneurysms

Clinica Chimica Acta

Volumn 391, Issue 1-2, 2008, Pages 41-45

  Götting, Christian ^a   Prante, Christian ^a   Schillinger, Martin ^b   Exner, Markus ^c   Domanovits, Hans ^b   Raith, Marianne ^c   Kuhn, Joachim ^a   Kleesiek, Knut ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

Abdominal aortic aneurysm; Genetic risk factor; Glycosaminoglycan; Proteoglycan; Xylosyltransferase

Indexed keywords

GLYCOSAMINOGLYCAN; PROTEOGLYCAN; TRANSFERASE; UNCLASSIFIED DRUG; XYLOSYLTRANSFERASE 1;

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; ALLELE; ARTICLE; BIOSYNTHESIS; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 41849134641     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2008.01.028     Document Type: Article

References (34)

1. Verloes A., Sakalihasan N., Limet R., and Koulischer L. Genetic aspects of abdominal aortic aneurysm. Ann N Y Acad Sci 800 (1996) 44-55
2. Belsley S.J., and Tilson M.D. Two decades of research on etiology and genetic factors in the abdominal aortic aneurysm (AAA)-with a glimpse into the 21st century. Acta Chir Belg 103 (2003) 187-196
3. Lederle F.A., Johnson G.R., Wilson S.E., et al. Prevalence and associations of abdominal aortic aneurysm detected through screening. Aneurysm Detection and Management (ADAM) Veterans Affairs Cooperative Study Group. Ann Intern Med 126 (1997) 441-449
4. Darling III R.C., Brewster D.C., Darling R.C., et al. Are familial abdominal aortic aneurysms different?. J Vasc Surg 10 (1989) 39-43
5. Prisant L.M., and Mondy III J.S. Abdominal aortic aneurysm. J Clin Hypertens (Greenwich) 6 (2004) 85-89
6. Verloes A., Sakalihasan N., Koulischer L., and Limet R. Aneurysms of the abdominal aorta: familial and genetic aspects in three hundred thirteen pedigrees. J Vasc Surg 21 (1995) 646-655
7. Crowther M., Brindle N.P., Sayers R., Bell P.R., and Thompson M.M. Aneurysmal smooth muscle cells exhibit increased matrix metalloproteinase-2 production in vitro. Ann N Y Acad Sci 800 (1996) 283-285
8. Satta J., Laurila A., Paakko P., et al. Chronic inflammation and elastin degradation in abdominal aortic aneurysm disease: an immunohistochemical and electron microscopic study. Eur J Vasc Endovasc Surg 15 (1998) 313-319
9. Alexander J.J. The pathobiology of aortic aneurysms. J Surg Res 117 (2004) 163-175
10. Dobrin P.B., and Mrkvicka R. Failure of elastin or collagen as possible critical connective tissue alterations underlying aneurysmal dilatation. Cardiovasc Surg 2 (1994) 484-488
11. Sobolewski K., Wolanska M., Bankowski E., Gacko M., and Glowinski S. Collagen, elastin and glycosaminoglycans in aortic aneurysms. Acta Biochim Pol 42 (1995) 301-307
12. Iozzo R.V. Matrix proteoglycans: from molecular design to cellular function. Annu Rev Biochem 67 (1998) 609-652
13. Wight T.N., Kinsella M.G., and Qwarnstrom E.E. The role of proteoglycans in cell adhesion, migration and proliferation. Curr Opin Cell Biol 4 (1992) 793-801
14. Tamarina N.A., Grassi M.A., Johnson D.A., and Pearce W.H. Proteoglycan gene expression is decreased in abdominal aortic aneurysms. J Surg Res 74 (1998) 76-80
15. Cherchi G.M., Coinu R., Demuro P., et al. Structural and functional modifications of human aorta proteoglycans in atherosclerosis. Matrix 10 (1990) 362-372
16. Theocharis A.D., Theocharis D.A., De Luca G., Hjerpe A., and Karamanos N.K. Compositional and structural alterations of chondroitin and dermatan sulfates during the progression of atherosclerosis and aneurysmal dilatation of the human abdominal aorta. Biochimie 84 (2002) 667-674
17. Theocharis A.D., Tsolakis I., Hjerpe A., and Karamanos N.K. Human abdominal aortic aneurysm is characterized by decreased versican concentration and specific downregulation of versican isoform V(0). Atherosclerosis 154 (2001) 367-376
18. Theocharis A.D., Tsolakis I., Tsegenidis T., and Karamanos N.K. Human abdominal aortic aneurysm is closely associated with compositional and specific structural modifications at the glycosaminoglycan level. Atherosclerosis 145 (1999) 359-368
19. Götting C., Kuhn J., and Kleesiek K. Human xylosyltransferases in health and disease. Cell Mol Life Sci 64 (2007) 1498-1517
20. Prante C., Milting H., Kassner A., et al. TGF-beta1 regulated xylosyltransferase I activity in human cardiac fibroblasts and its impact for myocardial remodeling. J Biol Chem 282 (2007) 26441-26449
21. Seo N.S., Hocking A.M., Hook M., and McQuillan D.J. Decorin core protein secretion is regulated by N-linked oligosaccharide and glycosaminoglycan additions. J Biol Chem 280 (2005) 42774-42784
22. Götting C., Sollberg S., Kuhn J., et al. Serum xylosyltransferase: a new biochemical marker of the sclerotic process in systemic sclerosis. J Invest Dermatol 112 (1999) 919-924
23. Götting C., Hendig D., Adam A., et al. Elevated xylosyltransferase I activities in pseudoxanthoma elasticum (PXE) patients as a marker of stimulated proteoglycan biosynthesis. J Mol Med 83 (2005) 984-992
24. Schön S., Huep G., Prante C., et al. Mutational and functional analyses of xylosyltransferases and their implication in osteoarthritis. Osteoarthritis Cartilage 14 (2006) 442-448
25. Schön S., Prante C., Müller S., et al. Impact of polymorphisms in the genes encoding xylosyltransferase I and a homologue in type 1 diabetic patients with and without nephropathy. Kidney Int 68 (2005) 1483-1490
26. Schön S., Prante C., Bahr C., et al. The xylosyltransferase I gene polymorphism c.343G > T (p.A125S) is a risk factor for diabetic nephropathy in Type 1 diabetes. Diabetes Care 29 (2006) 2295-2299
27. Schön S., Schulz V., Prante C., et al. Polymorphisms in the xylosyltransferase genes cause higher serum XT-I activity in patients with pseudoxanthoma elasticum (PXE) and are involved in a severe disease course. J Med Genet 43 (2006) 745-749
28. Johnston K.W., Rutherford R.B., Tilson M.D., Shah D.M., Hollier L., and Stanley J.C. Suggested standards for reporting on arterial aneurysms. Subcommittee on Reporting Standards for Arterial Aneurysms, Ad Hoc Committee on Reporting Standards, Society for Vascular Surgery and North American Chapter, International Society for Cardiovascular Surgery. J Vasc Surg 13 (1991) 452-458
29. Sasieni P.D. From genotypes to genes: doubling the sample size. Biometrics 53 (1997) 1253-1261
30. Skol A.D., Scott L.J., Abecasis G.R., and Boehnke M. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 38 (2006) 209-213
31. Dupont W.D., and Plummer Jr. W.D. Power and sample size calculations. A review and computer program. Control Clin Trials 11 (1990) 116-128
32. Kowalewski R., Sobolewski K., Malkowski A., Wolanska M., and Gacko M. Evaluation of enzymes involved in proteoglycan degradation in the wall of abdominal aortic aneurysms. J Vasc Res 43 (2006) 95-100
33. Schön S., Prante C., Bahr C., Kuhn J., Kleesiek K., and Götting C. Cloning and recombinant expression of active full-length xylosyltransferase I (XT-I) and characterization of subcellular localization of XT-I and XT-II. J Biol Chem 281 (2006) 14224-14231
34. Müller S., Disse J., Schöttler M., et al. Human xylosyltransferase I and N-terminal truncated forms: functional characterization of the core enzyme. Biochem J 394 (2006) 163-171